Drug nearly doubles survival rate for some pancreatic cancer patients, study finds
Some pancreatic cancer patients are seeing a nearly double rate of survival after using a new drug, according to new research. Dr. Harsh Singh, a program director at the MGB Cancer Institute, joins with more details.
Original Source
Read the full article at Cbsnews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.